24 completed, 6 terminated, 4 recruiting, 4 unknown. 14 Phase 2, 11 Not applicable, 5 Phase 3, 3 Phase 4, 2 Early Phase 1.
Follow Diabetic Gastroparesis: new trials by email Literature Review of Diabetic Gastroparesis trials Research Report on Diabetic Gastroparesis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Virtual Yoga in Diabetic Gastroparesis Patients Virtual Yoga - Diabetic Gastroparesis | Not applicable | Recruiting | Ohio State University | 240 | 2026-07-17 | 2026-07-21 |
| Pyloric Sphincter Abnormalities in Patients With Gastroparesis Symptoms Gastroparesis, Idiopathic Gastric Motility Disorder | Recruiting | Johns Hopkins Bloomberg School of Public Health | 150 | 2026-01-13 | 2026-04-03 | |
| Correlation Between Advanced Glycation End Products and Gastric Motility Disorder in Diabetes Gastroparesis Diabetic Gastroparesis | Recruiting | Northern Jiangsu People's Hospital | 50 | 2026-01-07 | 2026-02-17 | |
| Washed Microbiota Transplantation Alleviates Diabetic Gastrointestinal Motility Disorders: an Efficacy and Safety Study Washing Microbiota Transplantation - Diabetic Gastroparesis, Diabetic Gastropathy | Not applicable | Not yet recruiting | The Second Hospital of Nanjing Medical University | 40 | 2024-04-20 | 2024-04-03 |
| Washed Microbiota Transplantation for Diabetic Gastroparesis washed microbiota transplantation, placebo - Diabetic Gastroparesis | Not applicable | Recruiting | The Second Hospital of Nanjing Medical University | 46 | 2024-04-01 | 2026-08-05 |
| Open Label Safety Study of Tradipitant in Idiopathic and Diabetic Gastroparesis Tradipitant - Idiopathic Gastroparesis, Diabetic Gastroparesis | Phase 3 | Completed | Vanda Pharmaceuticals | 17 | 2024-01-09 | 2026-10-19 |
| Gastroparesis in type2 Diabetic Patient Diabetic Gastroparesis | Not yet recruiting | Assiut University | 100 | 2023-11-01 | 2023-01-17 | |
| Contrast-enhanced Multispectral Optoacoustic Tomography for Non-invasive Assessment of Diabetic Gastroparesis Multispectral Optoacoustic Tomography (MSOT) - Diabetic Gastroparesis | Not applicable | Unknown | University of Erlangen-Nürnberg Medical School | 40 | 2023-07-15 | 2023-07-07 |
| A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adults With Diabetic Gastroparesis CIN-102 Dose 15mg or 10mg, Placebo - Diabetic Gastroparesis | Phase 2 | Completed | CinDome Pharma, Inc. | 382 | 2023-03-27 | 2025-12-17 |
| Body Surface Gastric Mapping to Evaluate Patients With Upper Gastrointestinal Symptoms and Controls Gastric Alimetry System - Motility Disorder, Gastroparesis | Enrolling by invitation | University of Calgary | 400 | 2022-11-01 | 2026-10-15 | |
| Thoracic Neuromodulation for Diabetic Gastroparesis 2400 ThorS-MagNT Stimulations at 1Hz, 2400 ThorS-MagNT Stimulations at 10Hz, Sham Stimulations - Diabetic Gastroparesis | Not applicable | Completed | Medical University of South Carolina | 36 | 2022-07-27 | 2026-09-14 |
| Thoracic Splanchnic Magnetic Neuromodulation Therapy (ThorS-MagNT) for Grade 3 Diabetic Gastroparesis: Pilot Study Thoracic Splanchnic Magnetic Neuromodulation Therapy - Diabetic Gastroparesis | Early Phase 1 | Completed | Augusta University | 7 | 2020-11-05 | 2025-01-30 |
| A Study to Evaluate the Safety and Efficacy of NG101 in Adult Participants With Symptomatic Diabetic or Idiopathic Gastroparesis NG101, Placebo - Diabetic Gastroparesis, Idiopathic Gastroparesis | Phase 2 | Completed | Neurogastrx, Inc. | 161 | 2020-08-01 | 2025-08-28 |
| A Scintigraphy Study in Adults With Diabetic Gastroparesis CIN-102 Dose 1, CIN-102 Dose 2, Placebo for CIN-102 - Diabetic Gastroparesis | Phase 2 | Terminated | CinDome Pharma, Inc. | 2 | 2020-02-17 | 2021-08-10 |
| Evaluating the Safety and Efficacy of Tradipitant vs. Placebo in Idiopathic and Diabetic Gastroparesis Tradipitant, Placebo, Open Label Tradipitant - Idiopathic Gastroparesis, Diabetic Gastroparesis | Phase 3 | Completed | Vanda Pharmaceuticals | 979 | 2019-08-20 | 2026-09-24 |
| Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Exploratory Efficacy of Nimacimab in Patients With Diabetic Gastroparesis Nimacimab, Placebo - Diabetic Gastroparesis | Phase 2 | Unknown | Bird Rock Bio, Inc. | 6 | 2019-08-01 | 2020-01-18 |
| Rifaximin in Patients With Diabetic Gastroparesis Rifaximin, Placebo - Crohn Disease, Diabetic Gastroparesis | Phase 2 | Terminated | Mayo Clinic | 5 | 2019-06-14 | 2026-06-22 |
| Gastroparesis Registry 3 Gastroparesis, Diabetic Gastroparesis | Completed | Johns Hopkins Bloomberg School of Public Health | 406 | 2019-01-24 | 2024-05-24 | |
| A Study to Evaluate the Efficacy and Safety of TAK-906 in Adult Participants With Symptomatic Idiopathic or Diabetic Gastroparesis TAK-906 Maleate, Placebo - Diabetic Gastroparesis, Idiopathic Gastroparesis | Phase 2 | Completed | Millennium Pharmaceuticals, Inc. | 242 | 2018-10-14 | 2022-11-16 |
| Docusate/Senna for the Treatment of Diabetic Gastroparesis senna/docusate - Diabetic Gastroparesis | Phase 2 | Terminated | Wake Forest University Health Sciences | 2 | 2018-04-02 | 2024-10-03 |
Showing 20 of 46. Sign in to see all of them.
Gastroparesis (20) · Nausea (8) · Vomiting (8) · Diabetes Mellitus (7) · Stomach Diseases (3) · Abdominal Pain (2) · Digestive System Diseases (2) · Gastrointestinal Diseases (2) · Cannabinoid Hyperemesis Syndrome (1) · Crohn Disease (1) · Diabetes Mellitus, Type 1 (1) · Diabetes Mellitus, Type 2 (1) · Diabetic Neuropathies (1) · Familial cyclic vomiting syndrome (1) · Gastroesophageal Reflux (1)
Pathological Conditions, Signs and Symptoms (21) · Digestive System Diseases (20) · Gastrointestinal Diseases (20) · Signs and Symptoms (20) · Neurologic Manifestations (19) · Paralysis (19) · Stomach Diseases (17) · Endocrine System Diseases (8) · Glucose Metabolism Disorders (8) · Metabolic Diseases (8) · Nutritional and Metabolic Diseases (8) · Signs and Symptoms, Digestive (8) · Nervous System Diseases (2) · Pain (2) · Autoimmune Diseases (1)
Acupuncture Therapy (3) · Domperidone (2) · CIN-102 (1) · Cell Movement (1) · Endoscopic Ultrasound-Guided Fine Needle Aspiration (1) · Fecal Microbiota Transplantation (1) · Gastric Emptying (1) · Magnetic Resonance Spectroscopy (1) · Metoclopramide (1) · Nutritional Status (1) · Promethazine (1) · Quality of Life (1) · Rifaximin (1) · Saline Solution (1) · Sensation (1)
Johns Hopkins Bloomberg School of Public Health (4) · Evoke Pharma (3) · Vanda Pharmaceuticals (3) · CinDome Pharma, Inc. (2) · The Second Hospital of Nanjing Medical University (2) · Assiut University (1) · Augusta University (1) · Baylor Research Institute (1) · Bird Rock Bio, Inc. (1) · Changchun University of Chinese Medicine (1) · Dartmouth-Hitchcock Medical Center (1) · Göteborg University (1) · Ironwood Pharmaceuticals, Inc. (1) · Johns Hopkins University (1) · Liangzhou Wei (1)
United States (31) · China (4) · Belgium (2) · Germany (2) · Poland (2) · Canada (1) · Israel (1) · Japan (1) · Sweden (1) · Switzerland (1) · United Kingdom (1)
Henry Parkman, MD (2) · Amol Sharma, MD, MS (1) · Braden Kuo, MD (1) · Bradley Gose, MD (1) · Brian E Lacy (1) · Brian E. Lacy, MD (1) · Brian Murphy, MD, MPH (1) · Christopher N Andrews, MD MSc FRCPC (1) · Daniel Davis, DO (1) · Elsa Mondou, M.D. (1) · Faming Zhang (1) · Frank Hamilton, MD (1) · Frank Hamilton, MD, MPH (1) · Fuchun Wang, master (1)
PMID 22415019, PMID 22735166, PMID 23848826, PMID 24398454, PMID 24419482, PMID 25576687, PMID 26318833, PMID 26595907, PMID 26839980, PMID 27781342, PMID 28970332, PMID 29079987, PMID 29487566, PMID 30404035, PMID 30852767, PMID 31758430, PMID 32930463, PMID 33130007, PMID 33493377, PMID 33548234, PMID 33711180, PMID 33741641, PMID 34089855, PMID 34595805, PMID 34967147, PMID 35502871, PMID 36152902, PMID 37533380, PMID 37924856, PMID 38237696, PMID 39035685, PMID 40367443, PMID 42298424, PMID 42779231
U01DK073974 (4), U01DK073975 (4), U01DK073983 (4), U01DK074007 (4), U01DK073985 (2), U01DK074008 (2), U01DK074035 (2), U01DK112193 (2), U24DK074008 (2), 2018 (1), R01DK058697 (1), R43AT004489 (1), U24DK076169 (1), U24DK115255 (1)